Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...
Reexamination Certificate
1998-06-19
2003-06-03
Priebe, Scott D. (Department: 1636)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Introduction of a polynucleotide molecule into or...
C435S320100, C435S325000, C424S093210, C424S093200, C514S04400A, C536S024500
Reexamination Certificate
active
06573099
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates generally to synthetic genes for modifying endogenous gene expression in a cell, tissue or organ of a transgenic organism, in particular a transgenic animal or plant. More particularly, the present invention provides novel synthetic genes and genetic constructs which are capable of repressing delaying or otherwise reducing the expression of an endogenous gene or a target gene in an organism when introduced thereto.
BACKGROUND TO THE INVENTION
Controlling metabolic pathways in eukaryotic organisms is desirable for the purposes of producing novel traits therein or introducing novel traits into a particular cell, tissue or organ of said organism. Whilst recombinant DNA technology has provided significant progress in an understanding of the mechanisms regulating eukaryotic gene expression, much less progress has been made in the actual manipulation of gene expression to produce novel traits. Moreover, there are only limited means by which human intervention may lead to a repression, delay or reduction in eukaryotic gene expression.
Current methods for downregulating gene expression using recombinant DNA technology comprise the introduction of a transgene to the cell which is capable of repressing expression of an endogenous target gene, either transcriptionally or post-transcriptionally. However, the precise mechanism is not known. Moreover, the efficiency of current approaches is low and the results are variable and unpredictable.
Attempts to improve the accuracy and predictability of methods for regulating gene expression in cells, in particular the repression, delay or reduction in expression of viral target genes in eukaryotic cells, foreign transgenes or other foreign genes introduced into cells, tissues or organs by natural means, or endogenous genes which are expressed to produce undesirable traits for a particular purpose, have been largely unsuccessful possibly due to a lack of knowledge of the precise mechanisms involved. As a consequence, the efficiency of methods currently available remains low and highly variable.
In work leading up to the present invention, the inventors sought to elucidate the mechanisms involved in down-regulating gene expression in an attempt to provide improved methods therefor. In so doing the inventors have developed a wide range of synthetic genes capable of modulating gene expression in both prokaryotic and eukaryotic cells and genetic constructs comprising same.
Bibliographic details of the publications referred to by author in this specification are collected at the end of the description. Sequence identity numbers (SEQ ID NOs.) for the nucleotide and amino acid sequences referred to in the specification are defined after the bibliography.
Throughout this specification and the claims that follow, unless the context requires otherwise, the word “comprise”, or variations such as “comprises” or “comprising”, will be understood to imply the inclusion of a stated element or integer or group of elements or integers but not the exclusion of any other element or integer or group of elements or integers.
As used herein, the term “derived from” shall be taken to indicate that a particular integer or group of integers has originated from the species specified, but has not necessarily been obtained directly from the specified source.
SUMMARY OF THE INVENTION
The present invention provides novel synthetic genes and improved genetic constructs comprising same for modifying endogenous or target gene expression in cells, tissues and/or organs which are either transfected or stably transformed therewith.
Accordingly, one aspect of the present invention provides a synthetic gene which is capable of modifying target gene expression in a cell, tissue or organ of a prokaryotic or eukaryotic organism which is transfected or transformed therewith, wherein said synthetic gene at least comprises a structural gene sequence comprising a nucleotide sequence which is substantially identical to the nucleotide sequence of said target gene or a derivative thereof or a complementary sequence thereto placed operably under the control of a promoter sequence which is operable in said cell, tissue or organ.
A further aspect of the invention provides a synthetic gene which is capable of modifying the expression of a target gene in a cell, tissue or organ of a prokaryotic or eukaryotic organism which is transfected or transformed therewith, wherein said synthetic gene at least comprises multiple structural gene sequences, wherein each of said structural gene sequences comprises a nucleotide sequence which is substantially identical to the nucleotide sequence of said target gene or a derivative thereof or a complementary sequence thereto and wherein said multiple structural gene sequences are placed operably under the control of a single promoter sequence which is operable in said cell, tissue or organ.
A third aspect of the present invention provides a synthetic gene which is capable of modifying the expression of a target gene in a cell, tissue or organ of a prokaryote or eukaryote which is transfected or transformed therewith wherein said synthetic gene at least comprises multiple structural gene sequences wherein each of said structural gene sequences is placed operably under the control of a promoter sequence which is operable in said cell, tissue or organ and wherein each of said structural gene sequences comprises a nucleotide sequence which is substantially identical to the nucleotide sequence of said target gene or a derivative thereof or a complementary sequence thereto.
A further aspect of the present invention provides a genetic construct which is capable of modifying the expression of an endogenous gene or target gene in a transformed or transfected cell, tissue or organ wherein said genetic construct at least comprises the synthetic gene of the invention and one or more origins of replication and/or selectable marker gene sequences.
A still further aspect of the invention provides a cell, tissue, organ or organism comprising the synthetic genes and genetic constructs described herein.
REFERENCES:
patent: 5034323 (1991-07-01), Jorgensen et al.
patent: 5231020 (1993-07-01), Jorgensen et al.
patent: 5283184 (1994-02-01), Jorgensen et al.
patent: 5583021 (1996-12-01), Dougherty et al.
patent: 5686649 (1997-11-01), Chua et al.
patent: 5714323 (1998-02-01), Oshima et al.
patent: 0560156 (1993-09-01), None
patent: 0242016 (1997-10-01), None
patent: WO 90/11682 (1990-10-01), None
patent: WO 93/23551 (1993-11-01), None
patent: WO 94/17194 (1994-08-01), None
patent: WO 95/10607 (1995-04-01), None
patent: WO 96/08558 (1996-03-01), None
patent: WO 97/01952 (1997-01-01), None
patent: WO 98/36083 (1998-08-01), None
patent: WO 98/37213 (1998-08-01), None
patent: WO 98/44138 (1998-10-01), None
patent: WO 99/15682 (1999-04-01), None
patent: WO 99/25853 (1999-05-01), None
patent: WO 99/32619 (1999-07-01), None
Anderson WF, Nature 392:25-30, 1998.*
Verma et al Nature 389:239-242, 1997.*
Touchette, Nat. Med. 2(1) 7-8, 1996.*
Wang et al PNAS 94:11563-11566, 1997.*
Wall RJ Theriogenology 45:57-68, 1996.*
Kappel et al. Current Opinion in Biotechnology 3:548-553 1992.*
Viville, in Transgenic Animals, Houdebine (eds), Harwood academic publishers, France. pp307-321, 1997.*
Napoli, Carolyn et al., “Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans”,The Plant Cell, 2: 279-289 (1990).
Lindbo, John et al., “Induction of a Highly Specific Antiviral State in Transgenic Plants: Implications for Regulation of Gene Expression and Virus Resistance”,The Plant Cell, 5: 1749-1759 (1993).
Park, Y. et al., “Gene silencing mediated by promoter homology occurs at the level of transcription and results in meiotically heritable alterations in methylation and gene activity”,The Plant Journal, 9: 183-194 (1996).
Waterhouse, Peter et al., “Virus resistance and gene silencing in plants can be induced by simultaneous expression of sense and antisense RNA”,Plant Biology, 95: 13959-13
Benitec Australia, Ltd.
Kaushal Sumesh
Priebe Scott D.
Scully Scott Murphy & Presser
LandOfFree
Genetic constructs for delaying or repressing the expression... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic constructs for delaying or repressing the expression..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic constructs for delaying or repressing the expression... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3105083